2p15-16.1 microdeletion syndrome

As of 2013, only 21 patients with a 2p15-16.1 microdeletion had been identified. The clinical similarities between the individuals resulted in the classification of a new genetic syndrome. The shared clinical features include moderate to severe intellectual disability and similar facial features including telecanthus, drooping eyelids, downslanting, short palpebral fissures, a prominent nasal bridge, high palate with long, smooth philtrum and an everted lower lip. Some of the patients also had feeding problems in infancy, microcephaly, optic nerve hypoplasia and hydronephrosis, wide-spaced nipples, short stature, cortical dysplasia, camptodactyly and pigeon toe. ==Cause==

Three of the patients reported had a consistent proximal breakpoint on chromosome 2, but varying distal breakpoints. • AHSA2, activator of heat shock 90kDa protein ATPase homolog • BCL11A, B-cell lymphoma/leukemia 11A • C2orf74, Uncharacterized protein C2orf74 • FANCL, E3 ubiquitin-protein ligase FANCL • KIAA1841, Uncharacterized protein KIAA1841 • PAPOLG, Poly(A) polymerase gamma • PEX13, Peroxisomal membrane protein Peroxin-13 • PUS10, Pseudouridylate synthase 10 • REL, C-Rel proto-oncogene protein • SNORA70B, small nucleolar RNA, H/ACA box 70B • USP34, Ubiquitin carboxyl-terminal hydrolase 34 • VRK2, Serine/threonine-protein kinase VRK2 • XPO1, Exportin-1 ==References==